Sponsor Pipeline

Jiangsu HengRui Medicine Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
36
Active Trials
28
Recruiting
11
Phase 3
10
Disease Areas
8
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-11 NCT07556822
Phase I Study of HRS-3005 in B-cell Malignancies
Recruitment opened
2026-06-11 NCT06568094
A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced…
Trial arms changed: 4 -> 7
2026-06-05 NCT07472725
A Study Comparing Safety and Efficacy of SHR-3167 Fixed-Dose Titration and…
overall status: "Not Yet Recruiting" → "Active Not Recruiting"
2026-06-05 NCT07472725
A Study Comparing Safety and Efficacy of SHR-3167 Fixed-Dose Titration and…
Enrollment increased: 90 -> 102 participants
2026-06-05 NCT07036419
A Trial of Remimazolam for Intraoperative Sedation in Pediatric and Adolescent Patients
Trial completed
2026-05-30 NCT07404579
Safety and Efficacy of HRS-9190 Compared to Rocuronium for Bolus Maintenance in Adults
Trial completed
2026-05-30 NCT07404579
Safety and Efficacy of HRS-9190 Compared to Rocuronium for Bolus Maintenance in Adults
Enrollment increased: 90 -> 103 participants
2026-05-23 NCT05277168
A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904…
date change Primary completion pushed: 2026-03-03 -> 2026-05
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-05-27 NCT07610148 A Study to Estimate Effect of Formulation and Food on Relative Bioavailability of… Phase 1 Not Yet Recruiting
2026-05-15 NCT07588906 To Compare the Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability Between… Phase 1 Completed
Active Trials by Phase
Phase 3
11
Phase 2
10
Phase 1/2
6
Phase 1
9
Active Trials — top 25 of 36
NCT IDTitleConditionStatus
Phase 3
NCT06122389 SHR2554 Clinical Study of Chidamide in the Treatment of T-cell Lymphoma Relapsed/Refractory PTCLT With at Least One Line of Prior Systemic Therapy Recruiting
NCT04342910 Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With… Gastric Cancer Recruiting
NCT06430437 A Study of SHR-A1811 in First-line Treatment of Patients With Advanced or Metastatic… Non-Small Cell Lung Cancer With HER2- Mutations Recruiting
NCT07196774 A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in… Early-stage or Locally Advanced HER2-positive Breast Cancer Recruiting
NCT07311694 A Phase III Study Comparing HRS-4357 With Novel Androgen Receptor Pathway Inhibitors in… PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer Recruiting
NCT06828354 A Study of SHR-A1811 in Subjects With Ovarian Cancer Ovarian Cancer Recruiting
NCT07286032 A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in… Patients With Chemotherapy-Induced Thrombocytopenia Recruiting
NCT07241416 A Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive… Metastatic Hormone-sensitive Prostate Cancer (mHSPC) Recruiting
NCT05884255 An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With… Advanced Gastroenteropancreatic Neuroendocrine Tumor Recruiting
NCT04639180 A Study to Evaluate Camrelizumab Plus Rivoceranib (Apatinib) as Adjuvant Therapy in… Hepatocellular Carcinoma (HCC) Active, Not Recruiting
NCT06057610 A Phase III Study of SHR-A1811 Injection With or Without Pertuzumab in HER2-Positive… HER2-PositiveRecurrent or Metastatic Breast Cancer Active, Not Recruiting
Phase 2
NCT07251595 A Trial of SHR0302 Tablets and SHR0302 Base Gel in Patients With Non-segmental Vitiligo Non-segmental Vitiligo Recruiting
NCT07230106 A Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer Prostate Cancer Recruiting
NCT06529432 A Study of Bupivacaine Liposome Injection in the Treatment of Pain After Thoracoscopic… Local Analgesia Via Nerve Block Recruiting
NCT07372924 A Trial of Tegileridine Fumarate Lnjection for Prolonged Mechanical Ventilation… Abirritation in the ICU Recruiting
NCT07362355 The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the… Primary Gout and Hyperuricemia Recruiting
NCT07241767 A Phase II Clinical Study of FH-006 for Injection Combined With Other Anticancer… Lung Cancer Recruiting
NCT07446309 Safety and Efficacy of HRS-9190 Compared to Cisatracurium for Continuous Intravenous… Neuromuscular Blockade Recruiting
NCT07497386 A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast… Unresectable Locally Recurrent Breast Cancer Recruiting
NCT06790862 A Trial of SHR0302Base in Patients With Vitiligo Vitiligo Active, Not Recruiting
NCT07472725 A Study Comparing Safety and Efficacy of SHR-3167 Fixed-Dose Titration and… Diabetes Mellitus, Type 2 Active, Not Recruiting
Phase 1/2
NCT06974929 A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With… Breast Cancer Recruiting
NCT07446153 A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects Solid Tumor Recruiting
NCT05482568 A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects… Advanced Non-small Cell Lung Cancer Recruiting
NCT07407283 A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer Prostate Cancer Recruiting
View all 36 active Jiangsu HengRui Medicine Co., Ltd. trials with filters →
Disease Areas
Get alerts when Jiangsu HengRui Medicine Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free